The pattern of CD30L binding inhibition shows only limited correspondence to the functional capacity of some anti-CD30 MAb to trigger $T1$$T2$ binding inhibition shows only limited correspondence to the functional capacity of some anti-CD30 MAb to trigger CD30 signaling.
CD30
CD30L
0
The interface relies on the steric complementarity between the $T1$ cleft and the hydrophobic face of the p53 alpha helix and, in particular, on a triad of $T2$ amino acids-Phe19, Trp23, and Leu26-which insert deep into the MDM2 cleft.
MDM2
p53
0
The $T1$ and $T2$ receptors (hGHR and hPRLR, respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.
hGH
hPRL
0
CD5 associates with the $T1$ complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/$T2$ ligation.
T-cell receptor zeta chain (TcR zeta)/CD3
CD3
0
Here, we demonstrate that TR6 specifically binds two cellular ligands, LIGHT (herpes virus entry mediator ($T1$$T2$) and Fas ligand (FasL/CD95L).
HVEM
herpes virus entry mediator (HVEM)-L
0
Here, we demonstrate that TR6 specifically binds two cellular ligands, LIGHT (herpes virus entry mediator (HVEM)-L) and $T1$ (FasL/$T2$).
Fas ligand
CD95L
0
To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment to the interleukin 10 ($T1$$T2$, the STAT proteins activated by IL-10 in different cell populations were first defined using electrophoretic mobility shift assays.
IL-10
interleukin 10 (IL-10) receptor
0
A potential interaction of p75 and trkA $T1$$T2$ NGF receptors revealed by affinity crosslinking and immunoprecipitation.
NGF
trkA
0
We found that $T1$ and $T2$ can form a physical complex.
YY1
Sp1
1
CD5 associates with the $T1$ (TcR zeta)/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/$T2$ ligation.
T-cell receptor zeta chain
CD3
0
$T1$ and its counter-receptor CD30 ligand (CD30L) are members of the TNF-receptor/$T2$ superfamily and function to regulate lymphocyte survival and differentiation.
CD30
TNFalpha
0
Nerve growth factor binds independently to two transmembrane receptors, the $T1$ and the p140trk ($T2$) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.
p75 neurotrophin receptor
trkA
0
Prompted by this hypothesis, we analyzed the genomic region containing the gene for MPIF-2/$T1$ (SCYA24) and have identified a novel CC chemokine termed $T2$.
eotaxin-2
eotaxin-3
0
Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as p16 and p21 and regulators of apoptosis such as $T1$$T2$ and p21 and regulators of apoptosis such as p53 and members of the bcl-2 family.
p53
p16
0
In certain cancers, $T1$ amplification is a common event and contributes to the inactivation of $T2$.
MDM2
p53
0
CD5 associates with the T-cell receptor zeta chain ($T1$$T2$ associates with the T-cell receptor zeta chain (TcR zeta)/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/CD3 ligation.
TcR zeta
CD5
0
Molecular determinants of the interaction between the C-terminal domain of Alzheimer's $T1$ and $T2$ alpha-helices.
beta-amyloid peptide
apolipoprotein E
1
To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment to the $T1$$T2$ (IL-10) receptor, the STAT proteins activated by IL-10 in different cell populations were first defined using electrophoretic mobility shift assays.
interleukin 10 (IL-10) receptor
interleukin 10
0
We found that ADA was associated with $T1$ on T cell lines lacking either ADA or $T2$ enzymatic activity, indicating that the association between dipeptidyl peptidase IV and ADA did not require enzymatic activity.
CD26
dipeptidyl peptidase IV
0
If current models of chaperonin mechanism are correct, $T1$ undergoes more rebinding and release cycles than does $T2$.
rhodanese
GS
0
The genes for $T1$/eotaxin-2 (SCYA24) and eotaxin-3 ($T2$) are localized within a region of approximately 40 kilobases.
MPIF-2
SCYA26
0
In contrast, tyrosine-phosphorylated peptides containing Tyr374 or Tyr396 did not interact with Stat3 or block $T1$$T2$ or block Stat3 activation.
Stat3
Stat3
0
The binding properties of these variants in vitro, and the result of using a neutralizing monoclonal antibody directed against site 3, lead to the conclusion that $T1$ dimer is formed through direct binding at two independent and differently oriented sites on $T2$.
gp130
IL-6
0
Here, we demonstrate that TR6 specifically binds two cellular ligands, LIGHT (herpes virus entry mediator (HVEM)-L) and Fas ligand ($T1$/$T2$).
FasL
CD95L
0
Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as p16 and p21 and regulators of apoptosis such as p53 and members of the $T1$$T2$ and regulators of apoptosis such as p53 and members of the bcl-2 family.
bcl-2
p21
0
The POU domains of the $T1$ and $T2$ transcription factors mediate specific interaction with TBP.
Oct1
Oct2
0
Here, we demonstrate that TR6 specifically binds two cellular ligands, LIGHT (herpes virus entry mediator ($T1$)-L) and Fas ligand (FasL/$T2$).
HVEM
CD95L
0
Although multimeric complexes of trkA and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked $T1$$T2$ complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.
NGF
NGF-receptor
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like $T1$, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of $T2$, utrophin/dystrophin related protein, and the Torpedo 87K protein.
beta 1-syntrophin
dystrophin
1
Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist ($T1$$T2$ and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.
IL 1ra
transforming growth factors (TGF) beta1
0
Following gastrin stimulation, we observed a time- and dose-dependent association of IRS-1 with the $T1$$T2$ stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase).
p85
gastrin
0
Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), $T1$$T2$ and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.
CD14
transforming growth factors (TGF) beta1
0
These data demonstrate that $T1$ but not Stat1 or Stat5 is directly recruited to the ligand-activated $T2$ by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.
Stat3
IL-10 receptor
1
The extracellular domain of the human neurotrophin $T1$ receptor expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for brain-derived neurotrophic factor ($T2$).
TRKB
BDNF
0
The genes for MPIF-2/eotaxin-2 ($T1$) and $T2$ (SCYA26) are localized within a region of approximately 40 kilobases.
SCYA24
eotaxin-3
0
$T1$, a T cell activation Ag, also known as dipeptidyl peptidase IV,is directly associated with adenosine deaminase ($T2$) on the surface of T cells and T cell lines.
CD26
ADA
1
We found that $T1$ was associated with CD26 on T cell lines lacking either ADA or dipeptidyl peptidase IV enzymatic activity, indicating that the association between $T2$ and ADA did not require enzymatic activity.
ADA
dipeptidyl peptidase IV
0
CD5 associates with the $T1$$T2$ complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/CD3 ligation.
T-cell receptor zeta chain
T-cell receptor zeta chain (TcR zeta)/CD3
0
These data suggest that ADA on the cell surface is involved in an important immunoregulatory mechanism by which released $T1$ binds to cell surface $T2$, and this complex is capable of reducing the local concentration of adenosine.
ADA
CD26
1
Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist ($T1$$T2$ and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.
IL 1ra
tumour necrosis factors (TNF) alpha
0
We found that $T1$ was associated with CD26 on T cell lines lacking either ADA or $T2$ enzymatic activity, indicating that the association between dipeptidyl peptidase IV and ADA did not require enzymatic activity.
ADA
dipeptidyl peptidase IV
0
The resulting Trk variant recruited binding of NGF equivalent to $T1$, maintained neurotrophin-3 binding equivalent to $T2$, and also bound brain-derived neurotrophin, although with lower affinity compared with TrkB.
TrkA
TrkC
0
Our results indicate that the trkA and p75 receptors can potentially interact, and that such an association may be responsible for the generation of high affinity $T1$$T2$ receptors can potentially interact, and that such an association may be responsible for the generation of high affinity NGF binding sites.
NGF
p75
0
The $T1$ POU domain, which is highly homologous to the Oct2 POU domain, likewise mediates interaction with $T2$.
Oct1
TBP
1
We found that ADA was associated with CD26 on T cell lines lacking either $T1$ or dipeptidyl peptidase IV enzymatic activity, indicating that the association between $T2$ and ADA did not require enzymatic activity.
ADA
dipeptidyl peptidase IV
0
$T1$ also activated Stat5 in Ba/F3 cells that stably expressed the murine $T2$.
IL-10
IL-10 receptor
0
We have therefore investigated whether the octamer binding proteins might physically interact with $T1$, the TATA box binding protein component of the $T2$ factor.
TBP
TFIID
0
We found that ADA was associated with CD26 on T cell lines lacking either ADA or $T1$ enzymatic activity, indicating that the association between dipeptidyl peptidase IV and $T2$ did not require enzymatic activity.
dipeptidyl peptidase IV
ADA
0
Our data suggest that TR6 inhibits the interactions of LIGHT with $T1$/TR2 and $T2$, thereby suppressing LIGHT- mediated HT29 cell death.
HVEM
LTbetaR
0
Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist ($T1$), $T2$ (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.
IL 1ra
CD14
0
We demonstrate here that both the site 2 and site 3 IL-6 variants complexed with IL-6R alpha bind a single $T1$ molecule but are unable to dimerize it, whereas the combined site 2/3 variants lose the ability to interact with $T2$.
gp130
gp130
0
Further investigation indicated that the $T1$/MyoD heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by $T2$/HLH462.
ITF-2b
Id3
0
As expected, overexpression of either Id3/$T1$ or $T2$ effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor MyoD.
HLH462
ITF-2b
0
The potency of eotaxin-3 as a $T1$ ligand seems, however, to be approximately 10-fold less than that of $T2$.
CCR3
eotaxin
1
Although the individual amino acids in TrkA involved in binding to nerve growth factor ($T1$) and those in $T2$ involved in binding to neurotrophin-3 have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.
NGF
TrkC
0
Additional analysis revealed the presence of transcripts for both the activating ($T1$) and inhibitory ($T2$) isoforms in differentiating C2C12 cultures, suggesting that both isoforms might participate in regulating the differentiation process.
ITF-2a
ITF-2b
0
The resulting Trk variant recruited binding of NGF equivalent to $T1$, maintained neurotrophin-3 binding equivalent to TrkC, and also bound brain-derived neurotrophin, although with lower affinity compared with $T2$.
TrkA
TrkB
0
Evidence for physical interaction between the zinc-finger transcription factors $T1$ and $T2$.
YY1
Sp1
1
Although multimeric complexes of $T1$ and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked $T2$ complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.
trkA
NGF-receptor
0
$T1$ binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the $T2$, which are both co-expressed in the majority of neuronal cells that respond to NGF.
Nerve growth factor
p140trk (trkA) tyrosine kinase receptor
1
Here, we demonstrate that $T1$ specifically binds two cellular ligands, LIGHT (herpes virus entry mediator (HVEM)-L) and Fas ligand ($T2$/CD95L).
TR6
FasL
1
Comparisons with the hGH-hGHR complex reveal how $T1$$T2$ complex reveal how hGH can bind to the two distinctly different receptor binding surfaces.
hGH
hGHR
0
Our data suggest that TR6 inhibits the interactions of LIGHT with $T1$$T2$ inhibits the interactions of LIGHT with HVEM/TR2 and LTbetaR, thereby suppressing LIGHT- mediated HT29 cell death.
HVEM
TR6
0
Physical and functional interactions between the transcriptional inhibitors $T1$ and $T2$.
Id3
ITF-2b
1
Thus, TR6 may play a regulatory role for suppressing in FasL- and $T1$$T2$ may play a regulatory role for suppressing in FasL- and LIGHT-mediated cell death.
LIGHT
TR6
0
CD5 associates with the $T1$ (TcR zeta)/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of $T2$/CD3 ligation.
T-cell receptor zeta chain
TcR zeta
0
Although multimeric complexes of trkA and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked $T1$ complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked $T2$.
NGF-receptor
p75
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/$T1$ related protein, and the $T2$.
dystrophin
Torpedo 87K protein
0
We found that ADA was associated with $T1$ on T cell lines lacking either ADA or dipeptidyl peptidase IV enzymatic activity, indicating that the association between dipeptidyl peptidase IV and $T2$ did not require enzymatic activity.
CD26
ADA
0
$T1$ and its counter-receptor $T2$ ligand (CD30L) are members of the TNF-receptor/TNFalpha superfamily and function to regulate lymphocyte survival and differentiation.
CD30
CD30
0
We found that $T1$ was associated with CD26 on T cell lines lacking either ADA or dipeptidyl peptidase IV enzymatic activity, indicating that the association between dipeptidyl peptidase IV and $T2$ did not require enzymatic activity.
ADA
ADA
0
By using several different experimental systems we show that TBP efficiently associates with $T1$ and $T2$.
Oct1
Oct2
0
To study the mechanism underlying the apparent functional cooperation between $T1$ and $T2$, we explored the possibility of protein-protein interactions between these two transcription factors.
YY1
Sp1
0
The human pituitary hormones, $T1$ (hGH) and prolactin ($T2$), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.
growth hormone
hPRL
0
$T1$ and its counter-receptor CD30 ligand ($T2$) are members of the TNF-receptor/TNFalpha superfamily and function to regulate lymphocyte survival and differentiation.
CD30
CD30L
1
The helical cytokine $T1$ and its specific binding subunit IL-6R alpha form a 1:1 complex which, by promoting homodimerization of the signalling subunit $T2$ on the surface of target cells, triggers intracellular responses.
interleukin (IL) 6
gp130
0
The Oct1 POU domain, which is highly homologous to the $T1$ POU domain, likewise mediates interaction with $T2$.
Oct2
TBP
0
These data demonstrate that Stat3 but not $T1$$T2$ but not Stat1 or Stat5 is directly recruited to the ligand-activated IL-10 receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.
Stat1
Stat3
0
We have used an interaction cloning strategy to identify an inhibitory isoform of the ITF-2 transcription factor, $T1$, that interacts with the transcriptional inhibitor $T2$/HLH462.
ITF-2b
Id3
1
We have therefore investigated whether the octamer binding proteins might physically interact with $T1$, the $T2$ component of the TFIID factor.
TBP
TATA box binding protein
0
Finally, we demonstrate that the anti-CD30L MAb M81 also completely inhibits $T1$$T2$ MAb M81 also completely inhibits CD30/CD30L interaction.
CD30
CD30L
0
This information is useful for applying these MAbs in functional studies to further investigate the CD30/$T1$$T2$/CD30L system and for designing assays for soluble CD30L.
CD30L
CD30
0
We found that ADA was associated with CD26 on T cell lines lacking either ADA or dipeptidyl peptidase IV enzymatic activity, indicating that the association between $T1$ and $T2$ did not require enzymatic activity.
dipeptidyl peptidase IV
ADA
1
The crystal structure of the 109-residue amino-terminal domain of MDM2 bound to a 15-residue transactivation domain peptide of p53 revealed that $T1$$T2$ bound to a 15-residue transactivation domain peptide of p53 revealed that MDM2 has a deep hydrophobic cleft on which the p53 peptide binds as an amphipathic alpha helix.
MDM2
MDM2
0
Therefore, we suggested that this fragment is implicated in the neurotoxicity of $T1$ and in the protective effects of $T2$ in Alzheimer's disease.
Abeta
apolipoprotein E
0
Because cells lacking the protein tyrosine kinase c-Abl are also defective in radiation-induced G1 arrest, we investigated the possibility that $T1$$T2$ are also defective in radiation-induced G1 arrest, we investigated the possibility that ATM might interact with c-Abl in response to radiation damage.
ATM
c-Abl
0
The hGH and $T1$ receptors ($T2$ and hPRLR, respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.
hPRL
hGHR
0
TR6 ($T1$ ($T2$)) is a new member of the tumor necrosis factor receptor (TNFR) family.
decoy receptor 3
DcR3
0
Using a soluble CD30L/CD8alpha chimeric protein, we assessed the ability of anti-$T1$ MAb to inhibit the binding of CD30L to $T2$ expressed by the CD30+ Karpas 299 cell line.
CD30
CD30
0
As expected, overexpression of either Id3/HLH462 or ITF-2b effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor $T1$$T2$ effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor MyoD.
MyoD
ITF-2b
0
Characterization of the $T1$ binding domain on the human $T2$ molecule using anti-CD30 antibodies.
CD30L
CD30
1
Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules $T1$ and beta, transforming growth factors (TGF) beta1 and 2, $T2$ and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.
tumour necrosis factors (TNF) alpha
interleukin (IL) 1
0
In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of $T1$ receptor substrate 1 ($T2$), the major cytoplasmic substrate of the insulin receptor.
insulin
IRS-1
0
In addition, activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells, suggesting that tyrosine phosphorylation of IRS-1, which leads to the rapid recruitment of p85, might be one mechanism used by $T1$ to activate $T2$.
gastrin
PI 3-kinase
0
hPRL does not bind to the hGH receptor, but hGH binds to both the $T1$ and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on $T2$ overlap.
hGHR
hGH
0
Using a soluble $T1$/CD8alpha chimeric protein, we assessed the ability of anti-CD30 MAb to inhibit the binding of CD30L to $T2$ expressed by the CD30+ Karpas 299 cell line.
CD30L
CD30
0
Although multimeric complexes of $T1$ and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked NGF-receptor complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked $T2$.
trkA
p75
0
Co-transfection of human TBP and $T1$$T2$ and Oct2 expression vectors into B cells resulted in a synergistic activation of an octamer motif containing promoter.
Oct2
TBP
0
In all cells tested, $T1$ activated $T2$ and Stat3 and induced the formation of three distinct DNA binding complexes that contained different combinations of these two transcription factors.
IL-10
Stat1
1
We found that ADA was associated with CD26 on T cell lines lacking either ADA or $T1$ enzymatic activity, indicating that the association between $T2$ and ADA did not require enzymatic activity.
dipeptidyl peptidase IV
dipeptidyl peptidase IV
0
Here, we demonstrate that TR6 specifically binds two cellular ligands, LIGHT ($T1$) and Fas ligand (FasL/$T2$).
herpes virus entry mediator (HVEM)-L
CD95L
0
Further investigation indicated that the ITF-2b/MyoD heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by $T1$/$T2$.
Id3
HLH462
0
We further demonstrated that apolipoprotein E2 and E3 but not $T1$$T2$ and E3 but not apolipoprotein E4 can decrease the fusogenic activity of Abeta(29-42) via a direct interaction.
apolipoprotein E4
apolipoprotein E2
0
We found that ADA was associated with $T1$ on T cell lines lacking either ADA or dipeptidyl peptidase IV enzymatic activity, indicating that the association between $T2$ and ADA did not require enzymatic activity.
CD26
dipeptidyl peptidase IV
0
These data demonstrate that Stat3 but not Stat1 or $T1$$T2$ or Stat5 is directly recruited to the ligand-activated IL-10 receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.
Stat5
Stat1
0
Although multimeric complexes of trkA and $T1$ were not detected by affinity crosslinking, immunoprecipitation of cross-linked $T2$ complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.
p75
NGF-receptor
0
In this study, a minimum set of residues in the human TrkC second immunoglobulin-like domain, which does not bind $T1$ ($T2$), were substituted with those from human TrkA.
nerve growth factor
NGF
0
CD5 interaction with $T1$$T2$ p56lck represents a novel variant of a receptor-kinase complex in which receptor can also serve as substrate.
p56lck
ith
0
We have cloned and characterized human $T1$ and a second isoform of human $T2$.
acidic (alpha 1-) syntrophin
basic (beta 2-) syntrophin
0
IL-10 also activated $T1$ in Ba/F3 cells that stably expressed the murine $T2$ receptor.
Stat5
IL-10
0
As expected, overexpression of either Id3/HLH462 or ITF-2b effectively inhibited the activation of the muscle-specific $T1$ promoter by the myogenic transcription factor $T2$.
creatine kinase
MyoD
0
Using a soluble CD30L/$T1$ chimeric protein, we assessed the ability of anti-CD30 MAb to inhibit the binding of CD30L to $T2$ expressed by the CD30+ Karpas 299 cell line.
CD8alpha
CD30
0
Our data suggest that TR6 inhibits the interactions of LIGHT with HVEM/TR2 and $T1$, thereby suppressing $T2$- mediated HT29 cell death.
LTbetaR
LIGHT
0
By using several different experimental systems we show that $T1$ efficiently associates with Oct1 and $T2$.
TBP
Oct2
1
The genes for MPIF-2/$T1$ (SCYA24) and $T2$ (SCYA26) are localized within a region of approximately 40 kilobases.
eotaxin-2
eotaxin-3
0
$T1$ does not bind to the $T2$ receptor, but hGH binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.
hPRL
hGH
0
hPRL does not bind to the $T1$ receptor, but hGH binds to both the $T2$ and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.
hGH
hGHR
0
CD5 interaction with p56lck represents a novel variant of a receptor-kinas$T1$$T2$ represents a novel variant of a receptor-kinase complex in which receptor can also serve as substrate.
e compl
p56lck
0
We have previously reported that tyrosine phosphorylation of Shc and its association with the $T1$-Sos complex may contribute to the activation of the $T2$ pathway by gastrin.
Grb2
mitogen-activated protein kinase
0
CD30 and its counter-receptor CD30 ligand ($T1$) are members of the TNF-receptor/$T2$ superfamily and function to regulate lymphocyte survival and differentiation.
CD30L
TNFalpha
0
The rates of commitment to renaturation of $T1$ and $T2$ in the presence of the groE chaperonins.
rhodanese
glutamine synthetase
0
We report here that Grb2 also interacts with tyrosine-phosphorylated $T1$ in response to $T2$.
IRS-1
gastrin
0
In this study, a minimum set of residues in the human $T1$ second immunoglobulin-like domain, which does not bind nerve growth factor ($T2$), were substituted with those from human TrkA.
TrkC
NGF
0
Although the individual amino acids in $T1$ involved in binding to nerve growth factor ($T2$) and those in TrkC involved in binding to neurotrophin-3 have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.
TrkA
NGF
1
CD30 and its counter-receptor $T1$ (CD30L) are members of the TNF-receptor/$T2$ superfamily and function to regulate lymphocyte survival and differentiation.
CD30 ligand
TNFalpha
0
Our results indicate that the trkA and p75 receptors can potentially interact, and that such an association may be responsible for the generation of high affinity $T1$$T2$ and p75 receptors can potentially interact, and that such an association may be responsible for the generation of high affinity NGF binding sites.
NGF
trkA
0
Here, we demonstrate that TR6 specifically binds two cellular ligands, LIGHT ($T1$) and Fas ligand ($T2$/CD95L).
herpes virus entry mediator (HVEM)-L
FasL
0
The $T1$ oncoprotein is a cellular inhibitor of the $T2$ tumor suppressor in that it can bind the transactivation domain of p53 and downregulate its ability to activate transcription.
MDM2
p53
1
The resulting Trk variant recruited binding of NGF equivalent to TrkA, maintained $T1$ binding equivalent to TrkC, and also bound $T2$, although with lower affinity compared with TrkB.
neurotrophin-3
brain-derived neurotrophin
0
The interaction can also be observed in vivo, as $T1$ can be co-precipitated with Oct2 from co-transfected Cos1 cells and TBP co-immunoprecipitates with the endogenous $T2$ from HeLa cells.
TBP
Oct1
0
The ability of $T1$ to initiate transcription is augmented by the presence of a TATA motif or binding sites for transcription factor $T2$.
YY1
Sp1
0
We demonstrate here that both the site 2 and site 3 IL-6 variants complexed with $T1$ bind a single gp130 molecule but are unable to dimerize it, whereas the combined site 2/3 variants lose the ability to interact with $T2$.
IL-6R alpha
gp130
0
As expected, overexpression of either $T1$/$T2$ or ITF-2b effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor MyoD.
Id3
HLH462
0
Our data suggest that $T1$ inhibits the interactions of LIGHT with HVEM/TR2 and LTbetaR, thereby suppressing $T2$- mediated HT29 cell death.
TR6
LIGHT
0
Collectively, $T1$ is yet another functional ligand for $T2$.
eotaxin-3
CCR3
1
Nerve growth factor binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the $T1$ ($T2$) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.
p140trk
trkA
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor (LTbetaR) and HVEM/$T1$$T2$ (LTbetaR) and HVEM/TR2 receptors.
TR2
lymphotoxin beta receptor
0
Previously, we mapped the novel CC chemokine myeloid progenitor inhibitory factor 2 ($T1$$T2$ (MPIF-2)/eotaxin-2 to chromosome 7q11.23 (Nomiyama, H., Osborne, L. R., Imai, T., Kusuda, J., Miura, R., Tsui, L.-C., and Yoshie, O.
MPIF-2
myeloid progenitor inhibitory factor 2
0
The resulting Trk variant recruited binding of $T1$ equivalent to TrkA, maintained neurotrophin-3 binding equivalent to TrkC, and also bound $T2$, although with lower affinity compared with TrkB.
NGF
brain-derived neurotrophin
0
Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the $T1$$T2$ (IGF-IR) and the insulin receptor (IR) with their two known substrates p52Shc and the insulin receptor substrate-1 (IRS-1).
insulin-like growth factor-I
insulin-like growth factor-I receptor
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both $T1$ receptor ($T2$) and HVEM/TR2 receptors.
lymphotoxin beta
LTbetaR
1
Further investigation indicated that the $T1$/$T2$ heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by Id3/HLH462.
ITF-2b
MyoD
1
$T1$, a T cell activation Ag, also known as dipeptidyl peptidase IV,is directly associated with $T2$ (ADA) on the surface of T cells and T cell lines.
CD26
adenosine deaminase
1
IL-10 also activated Stat5 in Ba/F3 cells that stably expressed the murine $T1$$T2$.
IL-10
IL-10 receptor
0
To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment to the interleukin 10 ($T1$) receptor, the STAT proteins activated by $T2$ in different cell populations were first defined using electrophoretic mobility shift assays.
IL-10
IL-10
0
Although multimeric complexes of trkA and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked $T1$ complexes with $T2$-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.
NGF-receptor
trk
0
Following linkage studies which were most consistent with a beta spectrin gene mutation, a nucleotide change was identified in codon 2018, resulting in an Ala-->Gly substitution in the first helical domain of $T1$$T2$ gene mutation, a nucleotide change was identified in codon 2018, resulting in an Ala-->Gly substitution in the first helical domain of beta spectrin repeat 17.
beta spectrin
beta spectrin
0
Using a soluble $T1$/CD8alpha chimeric protein, we assessed the ability of anti-$T2$ MAb to inhibit the binding of CD30L to CD30 expressed by the CD30+ Karpas 299 cell line.
CD30L
CD30
0
Our data suggest that TR6 inhibits the interactions of LIGHT with HVEM/$T1$$T2$ inhibits the interactions of LIGHT with HVEM/TR2 and LTbetaR, thereby suppressing LIGHT- mediated HT29 cell death.
TR2
TR6
0
The genes for MPIF-2/$T1$ (SCYA24) and eotaxin-3 ($T2$) are localized within a region of approximately 40 kilobases.
eotaxin-2
SCYA26
0
CD5 associates with the $T1$$T2$ associates with the T-cell receptor zeta chain (TcR zeta)/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/CD3 ligation.
T-cell receptor zeta chain
CD5
0
Although the individual amino acids in TrkA involved in binding to $T1$ (NGF) and those in TrkC involved in binding to $T2$ have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.
nerve growth factor
neurotrophin-3
0
Cloning of the complete coding region for human $T1$ using the two hybrid system and expression of $T2$ in E. coli.
protein phosphatase inhibitor 2
inhibitor 2
0
The resulting Trk variant recruited binding of $T1$ equivalent to TrkA, maintained neurotrophin-3 binding equivalent to TrkC, and also bound brain-derived neurotrophin, although with lower affinity compared with $T2$.
NGF
TrkB
0
Molecular cloning of a novel human CC chemokine ($T1$) that is a functional ligand of $T2$.
Eotaxin-3
CC chemokine receptor 3
1
Coexpression of $T1$ with $T2$ in the baculovirus expression system resulted in the phosphorylation of CD5 on tyrosine residues.
CD5
p56lck
0
Following gastrin stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of $T1$$T2$ regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase).
phosphatidylinositol 3-kinase
p85
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of $T1$, utrophin/dystrophin related protein, and the $T2$.
dystrophin
Torpedo 87K protein
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ($T1$$T2$ (LTbetaR) and HVEM/TR2 receptors.
LTbetaR
lymphotoxin beta receptor
0
A newly identified member of tumor necrosis factor receptor superfamily ($T1$) suppresses $T2$-mediated apoptosis.
TR6
LIGHT
0
In the present study, we demonstrate that $T1$ stimulates tyrosine phosphorylation of $T2$ receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the insulin receptor.
gastrin
insulin
0
CD5 interaction with p56lck represents a novel variant of a receptor-kinas$T1$$T2$ p56lck represents a novel variant of a receptor-kinase complex in which receptor can also serve as substrate.
e compl
ith
0
Following gastrin stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of phosphatidylinositol 3-kinase ($T1$$T2$ regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase).
PI 3-kinase
p85
0
$T1$ interaction with $T2$ represents a novel variant of a receptor-kinase complex in which receptor can also serve as substrate.
CD5
p56lck
1
Nerve growth factor binds independently to two transmembrane receptors, the $T1$ neurotrophin receptor and the $T2$, which are both co-expressed in the majority of neuronal cells that respond to NGF.
p75
p140trk (trkA) tyrosine kinase receptor
0
Following gastrin stimulation, we observed a time- and dose-dependent association of IRS-1 with the $T1$$T2$ with the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase).
p85
IRS-1
0
The extracellular domain of the human neurotrophin TRKB receptor expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for $T1$$T2$ receptor expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for brain-derived neurotrophic factor (BDNF).
brain-derived neurotrophic factor
TRKB
0
Because cells lacking the protein tyrosine kinase c-Abl are also defective in radiation-induced G1 arrest, we investigated the possibility that ATM might interact with $T1$$T2$ are also defective in radiation-induced G1 arrest, we investigated the possibility that ATM might interact with c-Abl in response to radiation damage.
c-Abl
c-Abl
0
Coexpression of CD5 with $T1$ in the baculovirus expression system resulted in the phosphorylation of $T2$ on tyrosine residues.
p56lck
CD5
0
$T1$ associates with the $T2$ complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/CD3 ligation.
CD5
T-cell receptor zeta chain (TcR zeta)/CD3
1
These data demonstrate that Stat3 but not Stat1 or $T1$$T2$ but not Stat1 or Stat5 is directly recruited to the ligand-activated IL-10 receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.
Stat5
Stat3
0
Using immunoprecipitation techniques, we have determined the rates at which $T1$ and glutamine synthetase ($T2$) are released from groEL in a form committed to refold to active enzyme.
rhodanese
GS
0
The $T1$ oncoprotein is a cellular inhibitor of the p53 tumor suppressor in that it can bind the transactivation domain of $T2$ and downregulate its ability to activate transcription.
MDM2
p53
1
Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and $T1$$T2$ (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.
platelet endothelial cell adhesion molecule (PECAM) 1
CD14
0
Although the individual amino acids in $T1$ involved in binding to nerve growth factor (NGF) and those in TrkC involved in binding to $T2$ have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.
TrkA
neurotrophin-3
0
Interactions between $T1$ and the $T2$ receptor.
brain-derived neurotrophic factor
TRKB
0
Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and $T1$$T2$ and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.
platelet endothelial cell adhesion molecule (PECAM) 1
transforming growth factors (TGF) beta1
0
Using immunoprecipitation techniques, we have determined the rates at which rhodanese and $T1$ ($T2$) are released from groEL in a form committed to refold to active enzyme.
glutamine synthetase
GS
0
The human pituitary hormones, growth hormone ($T1$) and $T2$ (hPRL), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.
hGH
prolactin
0
Coexpression of $T1$ with p56lck in the baculovirus expression system resulted in the phosphorylation of $T2$ on tyrosine residues.
CD5
CD5
0
The resulting Trk variant recruited binding of NGF equivalent to TrkA, maintained $T1$ binding equivalent to $T2$, and also bound brain-derived neurotrophin, although with lower affinity compared with TrkB.
neurotrophin-3
TrkC
1
These same $T1$ residues are also involved in transactivation, supporting the hypothesis that MDM2 inactivates $T2$ by concealing its transactivation domain.
p53
p53
0
Our data suggest that TR6 inhibits the interactions of $T1$ with HVEM/$T2$ and LTbetaR, thereby suppressing LIGHT- mediated HT29 cell death.
LIGHT
TR2
1
The resulting Trk variant recruited binding of NGF equivalent to TrkA, maintained neurotrophin-3 binding equivalent to $T1$, and also bound $T2$, although with lower affinity compared with TrkB.
TrkC
brain-derived neurotrophin
0
The $T1$ and hPRL receptors (hGHR and $T2$, respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.
hGH
hPRLR
0
Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and $T1$$T2$ and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.
platelet endothelial cell adhesion molecule (PECAM) 1
tumour necrosis factors (TNF) alpha
0
More importantly, adenosine in the absence of cell surface ADA inhibited T cell proliferation and $T1$$T2$ inhibited T cell proliferation and IL-2 production induced by various stimuli.
IL-2
ADA
0
These data demonstrate that Stat3 but not Stat1 or $T1$ is directly recruited to the ligand-activated $T2$ by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.
Stat5
IL-10 receptor
0
We have previously reported that tyrosine phosphorylation of Shc and its association with the Grb2-$T1$ complex may contribute to the activation of the $T2$ pathway by gastrin.
Sos
mitogen-activated protein kinase
0
No binding between p59fyn(T) and $T1$$T2$(T) and CD5 was detected in T cells.
CD5
p59fyn
0
The genes for MPIF-2/eotaxin-2 ($T1$) and eotaxin-3 ($T2$) are localized within a region of approximately 40 kilobases.
SCYA24
SCYA26
0
In keeping with this observation, we showed that human CD26-transfected murine pre-B cell lines lacking human $T1$$T2$-transfected murine pre-B cell lines lacking human ADA acquired ADA from an extracellular source.
ADA
CD26
0
$T1$ binds independently to two transmembrane receptors, the $T2$ and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.
Nerve growth factor
p75 neurotrophin receptor
1
We found that $T1$ was associated with $T2$ on T cell lines lacking either ADA or dipeptidyl peptidase IV enzymatic activity, indicating that the association between dipeptidyl peptidase IV and ADA did not require enzymatic activity.
ADA
CD26
1
Here, we demonstrate that $T1$ specifically binds two cellular ligands, LIGHT ($T2$) and Fas ligand (FasL/CD95L).
TR6
herpes virus entry mediator (HVEM)-L
1
$T1$ does not bind to the hGH receptor, but hGH binds to both the $T2$ and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.
hPRL
hGHR
0
Using a soluble $T1$/CD8alpha chimeric protein, we assessed the ability of anti-CD30 MAb to inhibit the binding of $T2$ to CD30 expressed by the CD30+ Karpas 299 cell line.
CD30L
CD30L
0
Although multimeric complexes of $T1$ and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked $T2$-receptor complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.
trkA
NGF
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor (LTbetaR) and $T1$$T2$ receptor (LTbetaR) and HVEM/TR2 receptors.
HVEM
lymphotoxin beta
0
Anti-CD5 also precipitated the kinase from various T cells irrespective of the expression of TcR zeta/CD3 or $T1$$T2$ also precipitated the kinase from various T cells irrespective of the expression of TcR zeta/CD3 or CD4.
CD4
CD5
0
Although multimeric complexes of trkA and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked $T1$-receptor complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked $T2$.
NGF
p75
0
CD5 interaction with p56lck represents a novel variant of a receptor-kinas$T1$$T2$ interaction with p56lck represents a novel variant of a receptor-kinase complex in which receptor can also serve as substrate.
e compl
CD5
0
CD5 associates with the T-cell receptor zeta chain ($T1$)/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of $T2$/CD3 ligation.
TcR zeta
TcR zeta
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of $T1$, utrophin/$T2$ related protein, and the Torpedo 87K protein.
dystrophin
dystrophin
0
$T1$ associates with the T-cell receptor zeta chain (TcR zeta)/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/$T2$ ligation.
CD5
CD3
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and $T1$ interact with peptides encoding the syntrophin-binding region of dystrophin, $T2$/dystrophin related protein, and the Torpedo 87K protein.
alpha 1-syntrophin
utrophin
1
Although multimeric complexes of $T1$ and $T2$ were not detected by affinity crosslinking, immunoprecipitation of cross-linked NGF-receptor complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.
trkA
p75
0
The recently cloned $T1$ is such an $T2$.
YY1
Inr-binding protein
0
The genes for MPIF-2/eotaxin-2 (SCYA24) and $T1$ ($T2$) are localized within a region of approximately 40 kilobases.
eotaxin-3
SCYA26
0
Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated Stat3 but not $T1$$T2$ but not Stat1 and blocked IL-10-induced Stat3 phosphorylation in a cell-free system.
Stat1
Stat3
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor (LTbetaR) and HVEM/$T1$$T2$/TR2 receptors.
TR2
HVEM
0
We have therefore investigated whether the octamer binding proteins might physically interact with TBP, the $T1$ component of the $T2$ factor.
TATA box binding protein
TFIID
0
Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the $T1$ receptor ($T2$) and the insulin receptor (IR) with their two known substrates p52Shc and the insulin receptor substrate-1 (IRS-1).
insulin-like growth factor-I
IGF-IR
0
We found that ADA was associated with CD26 on T cell lines lacking either $T1$ or $T2$ enzymatic activity, indicating that the association between dipeptidyl peptidase IV and ADA did not require enzymatic activity.
ADA
dipeptidyl peptidase IV
0
Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist ($T1$$T2$ and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.
IL 1ra
interleukin (IL) 1
0
These results, obtained from a variety of experimental techniques, highlight the importance of two distinct regions of the extracellular domain of the $T1$ in binding $T2$.
TRKB receptor
BDNF
1
The hGH and hPRL receptors (hGHR and $T1$$T2$ and hPRLR, respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.
hPRLR
hGHR
0
Our data suggest that TR6 inhibits the interactions of LIGHT with HVEM/$T1$$T2$/TR2 and LTbetaR, thereby suppressing LIGHT- mediated HT29 cell death.
TR2
HVEM
0
Nerve growth factor binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the $T1$$T2$, which are both co-expressed in the majority of neuronal cells that respond to NGF.
p140trk
p140trk (trkA) tyrosine kinase receptor
0
Comparisons with the hGH-hGHR complex reveal how $T1$$T2$-hGHR complex reveal how hGH can bind to the two distinctly different receptor binding surfaces.
hGH
hGH
0
The resulting Trk variant recruited binding of $T1$ equivalent to TrkA, maintained neurotrophin-3 binding equivalent to $T2$, and also bound brain-derived neurotrophin, although with lower affinity compared with TrkB.
NGF
TrkC
0
Finally, we demonstrate that the anti-CD30L MAb M81 also completely inhibits $T1$/$T2$ interaction.
CD30
CD30L
1
The genes for $T1$/eotaxin-2 ($T2$) and eotaxin-3 (SCYA26) are localized within a region of approximately 40 kilobases.
MPIF-2
SCYA24
0
The genes for $T1$/$T2$ (SCYA24) and eotaxin-3 (SCYA26) are localized within a region of approximately 40 kilobases.
MPIF-2
eotaxin-2
0
Moreover, using immunoelectron microscopy, we demonstrated that CD26 and $T1$ co-localized on the cell surface, but not inside cells, suggesting that $T2$ did not transport ADA to the surface.
ADA
CD26
0
The deduced amino acid sequences of human alpha 1- and $T1$ are nearly identical to their homologues in mouse, suggesting a strong functional conservation among the individual isoforms, Much like beta 1-syntrophin, human $T2$ has multiple transcript classes and is expressed widely, although in a distinct pattern of relative abundance.
beta 2-syntrophin
beta 2-syntrophin
0
Our data suggest that TR6 inhibits the interactions of $T1$$T2$ inhibits the interactions of LIGHT with HVEM/TR2 and LTbetaR, thereby suppressing LIGHT- mediated HT29 cell death.
LIGHT
TR6
0
$T1$ stimulates tyrosine phosphorylation of $T2$ substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.
Gastrin
insulin receptor
0
Here, we demonstrate that $T1$ specifically binds two cellular ligands, LIGHT (herpes virus entry mediator (HVEM)-L) and $T2$ (FasL/CD95L).
TR6
Fas ligand
1
Here, we demonstrate that TR6 specifically binds two cellular ligands, $T1$ (herpes virus entry mediator (HVEM)-L) and $T2$ (FasL/CD95L).
LIGHT
Fas ligand
0
The physical interaction between $T1$ and $T2$ may thus form the basis for the functional interplay observed previously.
YY1
Sp1
1
Nerve growth factor binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the $T1$$T2$ binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.
p140trk
Nerve growth factor
0
The interaction can also be observed in vivo, as $T1$ can be co-precipitated with Oct2 from co-transfected Cos1 cells and $T2$ co-immunoprecipitates with the endogenous Oct1 from HeLa cells.
TBP
TBP
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and $T1$ interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/$T2$ related protein, and the Torpedo 87K protein.
alpha 1-syntrophin
dystrophin
0
Thus, TR6 may play a regulatory role for suppressing in $T1$$T2$ may play a regulatory role for suppressing in FasL- and LIGHT-mediated cell death.
FasL
TR6
0
Although the individual amino acids in $T1$ involved in binding to $T2$ (NGF) and those in TrkC involved in binding to neurotrophin-3 have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.
TrkA
nerve growth factor
1
Nerve growth factor binds independently to two transmembrane receptors, the $T1$ and the $T2$ (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.
p75 neurotrophin receptor
p140trk
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor (LTbetaR) and HVEM/$T1$$T2$ receptor (LTbetaR) and HVEM/TR2 receptors.
TR2
lymphotoxin beta
0
In this study, we simulated interactions of all amphipathic helices of $T1$ and A-I with $T2$ and simian immunodeficiency virus (SIV) fusogenic fragments by molecular modeling.
apolipoproteins E
Abeta
0
We expressed differently tagged forms of $T1$ and used them in solution-phase binding assays to show that the soluble extracellular domains of $T2$ undergo dimerization in the absence of membranes.
gp130
gp130
0
Prompted by this hypothesis, we analyzed the genomic region containing the gene for $T1$/eotaxin-2 ($T2$) and have identified a novel CC chemokine termed eotaxin-3.
MPIF-2
SCYA24
0
$T1$ does not bind to the hGH receptor, but hGH binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on $T2$ overlap.
hPRL
hGH
0
We demonstrate here that both the site 2 and site 3 $T1$ variants complexed with IL-6R alpha bind a single gp130 molecule but are unable to dimerize it, whereas the combined site 2/3 variants lose the ability to interact with $T2$.
IL-6
gp130
0
Taken together, our results suggest that $T1$ may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the $T2$.
IRS-1
insulin receptor
0
As expected, overexpression of either $T1$/HLH462 or ITF-2b effectively inhibited the activation of the muscle-specific $T2$ promoter by the myogenic transcription factor MyoD.
Id3
creatine kinase
0
We found that ADA was associated with CD26 on T cell lines lacking either $T1$ or dipeptidyl peptidase IV enzymatic activity, indicating that the association between dipeptidyl peptidase IV and $T2$ did not require enzymatic activity.
ADA
ADA
0
In addition, we identified domains within $T1$ and $T2$ that mediate their interactions with each other.
YY1
Sp1
1
The interface relies on the steric complementarity between the MDM2 cleft and the hydrophobic face of the p53 alpha helix and, in particular, on a triad of $T1$ amino acids-Phe19, Trp23, and Leu26-which insert deep into the $T2$ cleft.
p53
MDM2
1
Although multimeric complexes of trkA and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked $T1$-receptor complexes with $T2$-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.
NGF
trk
0
Evidence for a differential interaction of SHC and the insulin receptor substrate-1 (IRS-1) with the $T1$$T2$ (IGF-I) receptor in the yeast two-hybrid system.
insulin-like growth factor-I (IGF-I) receptor
insulin-like growth factor-I
0
The interface relies on the steric complementarity between the $T1$ cleft and the hydrophobic face of the p53 alpha helix and, in particular, on a triad of p53 amino acids-Phe19, Trp23, and Leu26-which insert deep into the $T2$ cleft.
MDM2
MDM2
0
The crystal structure of the 109-residue amino-terminal domain of MDM2 bound to a 15-residue transactivation domain peptide of p53 revealed that $T1$$T2$ revealed that MDM2 has a deep hydrophobic cleft on which the p53 peptide binds as an amphipathic alpha helix.
MDM2
p53
0
The human pituitary hormones, growth hormone (hGH) and prolactin ($T1$$T2$ (hPRL), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.
hPRL
prolactin
0
Nerve growth factor binds independently to two transmembrane receptors, the $T1$ neurotrophin receptor and the p140trk ($T2$) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.
p75
trkA
0
To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment to the $T1$ (IL-10) receptor, the STAT proteins activated by $T2$ in different cell populations were first defined using electrophoretic mobility shift assays.
interleukin 10
IL-10
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor (LTbetaR) and HVEM/$T1$$T2$) and HVEM/TR2 receptors.
TR2
LTbetaR
0
We had previously shown that the ubiquitous $T1$ and the lymphoid-specific $T2$ transcription factors stimulate transcription at the level of stable preinitiation complex formation.
Oct1
Oct2
0
The deduced amino acid sequences of human alpha 1- and $T1$ are nearly identical to their homologues in mouse, suggesting a strong functional conservation among the individual isoforms, Much like $T2$, human beta 2-syntrophin has multiple transcript classes and is expressed widely, although in a distinct pattern of relative abundance.
beta 2-syntrophin
beta 1-syntrophin
0
The extracellular domain of the human $T1$ expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for brain-derived neurotrophic factor ($T2$).
neurotrophin TRKB receptor
BDNF
1
Although multimeric complexes of trkA and $T1$ were not detected by affinity crosslinking, immunoprecipitation of cross-linked $T2$-receptor complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.
p75
NGF
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, $T1$/$T2$ related protein, and the Torpedo 87K protein.
utrophin
dystrophin
0
We report here that $T1$ also interacts with tyrosine-phosphorylated IRS-1 in response to $T2$.
Grb2
gastrin
0
The hGH and $T1$ receptors (hGHR and $T2$, respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.
hPRL
hPRLR
1
Two distinct ligand binding domains of TRKB were isolated from proteolytic digests of the receptor by affinity separation on immobilized $T1$$T2$ were isolated from proteolytic digests of the receptor by affinity separation on immobilized BDNF.
BDNF
TRKB
0
The genes for MPIF-2/$T1$ ($T2$) and eotaxin-3 (SCYA26) are localized within a region of approximately 40 kilobases.
eotaxin-2
SCYA24
0
IL-10 also activated $T1$ in Ba/F3 cells that stably expressed the murine $T2$.
Stat5
IL-10 receptor
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like $T1$, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, $T2$/dystrophin related protein, and the Torpedo 87K protein.
beta 1-syntrophin
utrophin
1
A potential interaction of $T1$ and trkA $T2$ receptors revealed by affinity crosslinking and immunoprecipitation.
p75
NGF
0
The genes for $T1$/eotaxin-2 (SCYA24) and $T2$ (SCYA26) are localized within a region of approximately 40 kilobases.
MPIF-2
eotaxin-3
0
These findings indicate that $T1$ is involved in the activation of $T2$ by DNA damage and this interaction may in part mediate radiation-induced G1 arrest.
ATM
c-Abl
1
As expected, overexpression of either Id3/HLH462 or ITF-2b effectively inhibited the activation of the muscle-specific $T1$$T2$ or ITF-2b effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor MyoD.
creatine kinase
HLH462
0
$T1$ recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the $T2$ receptor intracellular domain.
Stat3
interleukin-10
0
Our data suggest that TR6 inhibits the interactions of LIGHT with HVEM/$T1$ and LTbetaR, thereby suppressing $T2$- mediated HT29 cell death.
TR2
LIGHT
0
We further demonstrated that $T1$ and E3 but not apolipoprotein E4 can decrease the fusogenic activity of $T2$(29-42) via a direct interaction.
apolipoprotein E2
Abeta
1
Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and $T1$$T2$ and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.
platelet endothelial cell adhesion molecule (PECAM) 1
interleukin (IL) 1
0
In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 ($T1$), the major cytoplasmic substrate of the $T2$.
IRS-1
insulin receptor
0
$T1$ induced transient calcium mobilization specifically in $T2$ (CCR3)-expressing L1.2 cells with an EC(50) of 3 nM.
Eotaxin-3
CC chemokine receptor 3
0
In this study, a minimum set of residues in the human TrkC second immunoglobulin-like domain, which does not bind nerve growth factor (NGF), were substituted with those from human $T1$$T2$), were substituted with those from human TrkA.
TrkA
NGF
0
Taken together, our results suggest that $T1$ may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the $T2$ receptor.
IRS-1
insulin
0
To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment to the $T1$, the STAT proteins activated by $T2$ in different cell populations were first defined using electrophoretic mobility shift assays.
interleukin 10 (IL-10) receptor
IL-10
0
Here, we demonstrate that TR6 specifically binds two cellular ligands, $T1$ ($T2$) and Fas ligand (FasL/CD95L).
LIGHT
herpes virus entry mediator (HVEM)-L
0
Further investigation indicated that the ITF-2b/$T1$ heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by Id3/$T2$.
MyoD
HLH462
0
Although the individual amino acids in TrkA involved in binding to $T1$ (NGF) and those in $T2$ involved in binding to neurotrophin-3 have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.
nerve growth factor
TrkC
0
Although multimeric complexes of trkA and $T1$ were not detected by affinity crosslinking, immunoprecipitation of cross-linked NGF-receptor complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked $T2$.
p75
p75
0
Stat3 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the $T1$$T2$ receptor intracellular domain.
interleukin-10 receptor
interleukin-10
0
CD26, a T cell activation Ag, also known as $T1$,is directly associated with $T2$ (ADA) on the surface of T cells and T cell lines.
dipeptidyl peptidase IV
adenosine deaminase
1
Interaction between $T1$ protein and $T2$ in response to DNA damage.
ATM
c-Abl
1
Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the $T1$$T2$ may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the insulin receptor.
gastrin
IRS-1
0
These same p53 residues are also involved in transactivation, supporting the hypothesis that $T1$ inactivates $T2$ by concealing its transactivation domain.
MDM2
p53
1
Evidence for a differential interaction of SHC and the insulin receptor substrate-1 (IRS-1) with the $T1$$T2$) receptor in the yeast two-hybrid system.
insulin-like growth factor-I (IGF-I) receptor
IGF-I
0
The interface relies on the steric complementarity between the $T1$ cleft and the hydrophobic face of the $T2$ alpha helix and, in particular, on a triad of p53 amino acids-Phe19, Trp23, and Leu26-which insert deep into the MDM2 cleft.
MDM2
p53
0
Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated Stat3 but not Stat1 and blocked IL-10-induced $T1$$T2$-induced Stat3 phosphorylation in a cell-free system.
Stat3
IL-10
0
The T-cell antigen $T1$ acts as a receptor and substrate for the protein-tyrosine kinase $T2$.
CD5
p56lck
1
Our results demonstrate that the SH3 domain of $T1$ interacts with a DPAPNPPHFP motif (residues 1,373-1,382) of $T2$.
c-Abl
ATM
1
Moreover, using immunoelectron microscopy, we demonstrated that CD26 and $T1$ co-localized on the cell surface, but not inside cells, suggesting that CD26 did not transport $T2$ to the surface.
ADA
ADA
0
On the other hand, cells expressing ADA and $T1$$T2$ and CD26 on the surface were much more resistant to the inhibitory effect of adenosine.
CD26
ADA
0
The $T1$ and hPRL receptors ($T2$ and hPRLR, respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.
hGH
hGHR
1
The crystal structure of the human cyclinA-$T1$ ($T2$)-ATP complex has been determined at 2.3 A resolution.
cyclin-dependent kinase2
CDK2
0
$T1$ binding by $T2$ is blocked by MAb that recognize epitopes belonging to cluster Group A (like Ber-H2, Ber-H8, and HRS-4) as well as cluster Group C (like HeFi-1 and M44).
CD30L
CD30
1
We have used an interaction cloning strategy to identify an inhibitory isoform of the ITF-2 transcription factor, $T1$, that interacts with the transcriptional inhibitor Id3/$T2$.
ITF-2b
HLH462
1
The pattern of CD30L binding inhibition shows only limited correspondence to the functional capacity of some anti-CD30 MAb to trigger $T1$$T2$ MAb to trigger CD30 signaling.
CD30
CD30
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, $T1$/dystrophin related protein, and the $T2$.
utrophin
Torpedo 87K protein
0
Prompted by this hypothesis, we analyzed the genomic region containing the gene for $T1$/eotaxin-2 (SCYA24) and have identified a novel CC chemokine termed $T2$.
MPIF-2
eotaxin-3
0
The crystal structure of the human $T1$-cyclin-dependent kinase2 ($T2$)-ATP complex has been determined at 2.3 A resolution.
cyclinA
CDK2
1
Activin A, a member of the $T1$$T2$, a member of the TGFbeta superfamily, has various effects on diverse biological systems, including cell growth inhibition in many cell types.
TGFbeta
Activin A
0
Anti-CD5 also precipitated the kinase from various T cells irrespective of the expression of $T1$$T2$ also precipitated the kinase from various T cells irrespective of the expression of TcR zeta/CD3 or CD4.
TcR zeta
CD5
0
$T1$ associates with the T-cell receptor zeta chain (TcR zeta)/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of $T2$/CD3 ligation.
CD5
TcR zeta
0
The resulting Trk variant recruited binding of NGF equivalent to $T1$, maintained $T2$ binding equivalent to TrkC, and also bound brain-derived neurotrophin, although with lower affinity compared with TrkB.
TrkA
neurotrophin-3
0
Previously, we mapped the novel CC chemokine myeloid progenitor inhibitory factor 2 (MPIF-2)/$T1$$T2$ (MPIF-2)/eotaxin-2 to chromosome 7q11.23 (Nomiyama, H., Osborne, L. R., Imai, T., Kusuda, J., Miura, R., Tsui, L.-C., and Yoshie, O.
eotaxin-2
myeloid progenitor inhibitory factor 2
0
The helical cytokine interleukin (IL) 6 and its specific binding subunit $T1$ form a 1:1 complex which, by promoting homodimerization of the signalling subunit $T2$ on the surface of target cells, triggers intracellular responses.
IL-6R alpha
gp130
0
Our data suggest that TR6 inhibits the interactions of $T1$ with HVEM/TR2 and LTbetaR, thereby suppressing $T2$- mediated HT29 cell death.
LIGHT
LIGHT
0
Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as $T1$ and $T2$ and regulators of apoptosis such as p53 and members of the bcl-2 family.
p16
p21
0
We have used an interaction cloning strategy to identify an inhibitory isoform of the ITF-2 transcription factor, ITF-2b, that interacts with the transcriptional inhibitor Id3/$T1$$T2$/HLH462.
HLH462
Id3
0
We further demonstrated that apolipoprotein E2 and E3 but not $T1$ can decrease the fusogenic activity of $T2$(29-42) via a direct interaction.
apolipoprotein E4
Abeta
0
The potency of eotaxin-3 as a CCR3 ligand seems, however, to be approximately 10-fold less than that of $T1$$T2$ as a CCR3 ligand seems, however, to be approximately 10-fold less than that of eotaxin.
eotaxin
eotaxin-3
0
$T1$ also activated $T2$ in Ba/F3 cells that stably expressed the murine IL-10 receptor.
IL-10
Stat5
1
Nerve growth factor binds independently to two transmembrane receptors, the $T1$$T2$ neurotrophin receptor and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.
p75 neurotrophin receptor
p75
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like $T1$, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/$T2$ related protein, and the Torpedo 87K protein.
beta 1-syntrophin
dystrophin
0
Nerve growth factor binds independently to two transmembrane receptors, the $T1$ neurotrophin receptor and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to $T2$.
p75
NGF
0
Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), $T1$$T2$ and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.
CD14
tumour necrosis factors (TNF) alpha
0
Here, we demonstrate that TR6 specifically binds two cellular ligands, LIGHT (herpes virus entry mediator ($T1$)-L) and $T2$ (FasL/CD95L).
HVEM
Fas ligand
0
Evidence for a differential interaction of SHC and the insulin receptor substrate-1 (IRS-1) with the $T1$$T2$ and the insulin receptor substrate-1 (IRS-1) with the insulin-like growth factor-I (IGF-I) receptor in the yeast two-hybrid system.
insulin-like growth factor-I (IGF-I) receptor
SHC
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like $T1$, both beta 2- and $T2$ interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.
beta 1-syntrophin
alpha 1-syntrophin
0
hPRL does not bind to the $T1$ receptor, but $T2$ binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.
hGH
hGH
0
$T1$ induced transient calcium mobilization specifically in CC chemokine receptor 3 ($T2$)-expressing L1.2 cells with an EC(50) of 3 nM.
Eotaxin-3
CCR3
0
These data demonstrate that Stat3 but not Stat1 or Stat5 is directly recruited to the ligand-activated $T1$$T2$ is directly recruited to the ligand-activated IL-10 receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.
IL-10
Stat5
0
Our data suggest that $T1$ inhibits the interactions of LIGHT with HVEM/TR2 and $T2$, thereby suppressing LIGHT- mediated HT29 cell death.
TR6
LTbetaR
0
Nerve growth factor binds independently to two transmembrane receptors, the $T1$ and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to $T2$.
p75 neurotrophin receptor
NGF
0
Using a soluble CD30L/$T1$ chimeric protein, we assessed the ability of anti-CD30 MAb to inhibit the binding of $T2$ to CD30 expressed by the CD30+ Karpas 299 cell line.
CD8alpha
CD30L
0
Our results indicate that the trkA and $T1$$T2$ and p75 receptors can potentially interact, and that such an association may be responsible for the generation of high affinity NGF binding sites.
p75
trkA
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like $T1$, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the $T2$.
beta 1-syntrophin
Torpedo 87K protein
1
Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules $T1$ and beta, $T2$ and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.
tumour necrosis factors (TNF) alpha
transforming growth factors (TGF) beta1
0
A potential interaction of $T1$ and $T2$ NGF receptors revealed by affinity crosslinking and immunoprecipitation.
p75
trkA
0
$T1$ and $T2$ were chosen as substrates because they exhibit different solution requirements for the chaperonin system and they form stable "folding arrested" complexes with groEL.
Rhodanese
glutamine synthetase
0
Following gastrin stimulation, we observed a time- and dose-dependent association of $T1$$T2$ stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase).
IRS-1
gastrin
0
Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and $T1$$T2$), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.
platelet endothelial cell adhesion molecule (PECAM) 1
IL 1ra
0
We have previously reported that tyrosine phosphorylation of Shc and its association with the $T1$-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by $T2$.
Grb2
gastrin
0
Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated Stat3 but not Stat1 and blocked IL-10-induced $T1$$T2$ but not Stat1 and blocked IL-10-induced Stat3 phosphorylation in a cell-free system.
Stat3
Stat3
0
Characterization of the CD30L binding domain on the human CD30 molecule using anti-$T1$$T2$ molecule using anti-CD30 antibodies.
CD30
CD30
0
Here, we demonstrate that TR6 specifically binds two cellular ligands, LIGHT (herpes virus entry mediator (HVEM)-L) and $T1$ ($T2$/CD95L).
Fas ligand
FasL
0
In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of $T1$ ($T2$), the major cytoplasmic substrate of the insulin receptor.
insulin receptor substrate 1
IRS-1
0
Somatic cell hybrids and fluorescent in situ hybridization were both used to determine their chromosomal locations: $T1$ to chromosome 16q22-23 and $T2$ to chromosome 20q11.2.
beta 2-syntrophin
alpha 1-syntrophin
0
We have used an interaction cloning strategy to identify an inhibitory isoform of the $T1$ transcription factor, ITF-2b, that interacts with the transcriptional inhibitor Id3/$T2$.
ITF-2
HLH462
0
Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as p16 and p21 and regulators of apoptosis such as $T1$$T2$ and regulators of apoptosis such as p53 and members of the bcl-2 family.
p53
p21
0
The MDM2 oncoprotein is a cellular inhibitor of the $T1$ tumor suppressor in that it can bind the transactivation domain of $T2$ and downregulate its ability to activate transcription.
p53
p53
0
In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of $T1$$T2$ (IRS-1), the major cytoplasmic substrate of the insulin receptor.
insulin
insulin receptor substrate 1
0
As expected, overexpression of either $T1$/HLH462 or $T2$ effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor MyoD.
Id3
ITF-2b
0
Further investigation indicated that the $T1$/MyoD heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by Id3/$T2$.
ITF-2b
HLH462
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor (LTbetaR) and $T1$$T2$ (LTbetaR) and HVEM/TR2 receptors.
HVEM
lymphotoxin beta receptor
0
Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), $T1$$T2$ and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.
CD14
interleukin (IL) 1
0
hPRL does not bind to the $T1$ receptor, but hGH binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on $T2$ overlap.
hGH
hGH
0
As expected, overexpression of either Id3/HLH462 or ITF-2b effectively inhibited the activation of the muscle-specific $T1$$T2$ effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor MyoD.
creatine kinase
ITF-2b
0
The gene mutated in the autosomal recessive disorder ataxia telangiectasia (AT), designated $T1$ (for '$T2$'), is a member of a family of phosphatidylinositol-3-kinase-like enzymes that are involved in cell-cycle control, meiotic recombination, telomere length monitoring and DNA-damage response.
ATM
AT mutated
0
Anti-CD5 also precipitated the kinase from various T cells irrespective of the expression of TcR zeta/$T1$$T2$/CD3 or CD4.
CD3
TcR zeta
0
The human pituitary hormones, $T1$ (hGH) and $T2$ (hPRL), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.
growth hormone
prolactin
0
Our data suggest that TR6 inhibits the interactions of LIGHT with HVEM/$T1$ and $T2$, thereby suppressing LIGHT- mediated HT29 cell death.
TR2
LTbetaR
0
The crystal structure of the 109-residue amino-terminal domain of MDM2 bound to a 15-residue transactivation domain peptide of p53 revealed that MDM2 has a deep hydrophobic cleft on which the $T1$$T2$ revealed that MDM2 has a deep hydrophobic cleft on which the p53 peptide binds as an amphipathic alpha helix.
p53
p53
0
In all cells tested, $T1$ activated Stat1 and $T2$ and induced the formation of three distinct DNA binding complexes that contained different combinations of these two transcription factors.
IL-10
Stat3
1
These data demonstrate that Stat3 but not Stat1 or Stat5 is directly recruited to the ligand-activated $T1$$T2$ or Stat5 is directly recruited to the ligand-activated IL-10 receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.
IL-10
Stat1
0
Eotaxin-3 competed the binding of (125)$T1$$T2$ competed the binding of (125)I-eotaxin to CCR3-expressing L1.2 cells with an IC(50) of 13 nM.
I-eotaxin
Eotaxin-3
0
Structure of the $T1$ oncoprotein bound to the $T2$ tumor suppressor transactivation domain.
MDM2
p53
1
Here, we demonstrate that $T1$ specifically binds two cellular ligands, LIGHT (herpes virus entry mediator (HVEM)-L) and Fas ligand (FasL/$T2$).
TR6
CD95L
1
Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated Stat3 but not Stat1 and blocked $T1$$T2$ but not Stat1 and blocked IL-10-induced Stat3 phosphorylation in a cell-free system.
IL-10
Stat3
0
$T1$ does not bind to the hGH receptor, but $T2$ binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.
hPRL
hGH
0
Eotaxin-3 induced transient calcium mobilization specifically in $T1$ ($T2$)-expressing L1.2 cells with an EC(50) of 3 nM.
CC chemokine receptor 3
CCR3
0
In all cells tested, IL-10 activated $T1$ and $T2$ and induced the formation of three distinct DNA binding complexes that contained different combinations of these two transcription factors.
Stat1
Stat3
0
The extracellular domain of the human $T1$ expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for $T2$ (BDNF).
neurotrophin TRKB receptor
brain-derived neurotrophic factor
1
hPRL does not bind to the hGH receptor, but $T1$ binds to both the $T2$ and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.
hGH
hGHR
1
TR6 ($T1$$T2$ (decoy receptor 3 (DcR3)) is a new member of the tumor necrosis factor receptor (TNFR) family.
decoy receptor 3
TR6
0
Here, we demonstrate that TR6 specifically binds two cellular ligands, $T1$ (herpes virus entry mediator (HVEM)-L) and Fas ligand ($T2$/CD95L).
LIGHT
FasL
0
Moreover, using immunoelectron microscopy, we demonstrated that $T1$ and $T2$ co-localized on the cell surface, but not inside cells, suggesting that CD26 did not transport ADA to the surface.
CD26
ADA
0
In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the $T1$$T2$.
insulin
insulin receptor
0
Nerve growth factor binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the $T1$ (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to $T2$.
p140trk
NGF
0
Moreover, using immunoelectron microscopy, we demonstrated that CD26 and ADA co-localized on the cell surface, but not inside cells, suggesting that $T1$ did not transport $T2$ to the surface.
CD26
ADA
0
Here we show that $T1$ binds $T2$ constitutively in control cells but not in AT cells.
ATM
c-Abl
1
The resulting Trk variant recruited binding of $T1$ equivalent to TrkA, maintained $T2$ binding equivalent to TrkC, and also bound brain-derived neurotrophin, although with lower affinity compared with TrkB.
NGF
neurotrophin-3
0
The resulting Trk variant recruited binding of $T1$ equivalent to $T2$, maintained neurotrophin-3 binding equivalent to TrkC, and also bound brain-derived neurotrophin, although with lower affinity compared with TrkB.
NGF
TrkA
1
hPRL does not bind to the hGH receptor, but hGH binds to both the hGHR and $T1$, and mutagenesis studies have shown that the receptor-binding sites on $T2$ overlap.
hPRLR
hGH
0
Here, we demonstrate that $T1$ specifically binds two cellular ligands, LIGHT (herpes virus entry mediator ($T2$)-L) and Fas ligand (FasL/CD95L).
TR6
HVEM
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ($T1$$T2$ triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor (LTbetaR) and HVEM/TR2 receptors.
LTbetaR
LIGHT
0
In this study, a minimum set of residues in the human $T1$ second immunoglobulin-like domain, which does not bind nerve growth factor (NGF), were substituted with those from human $T2$.
TrkC
TrkA
0
Moreover, using immunoelectron microscopy, we demonstrated that $T1$ and ADA co-localized on the cell surface, but not inside cells, suggesting that $T2$ did not transport ADA to the surface.
CD26
CD26
0
Identification of $T1$ will further promote our understanding of the control of eosinophil trafficking and other $T2$-mediated biological phenomena.
eotaxin-3
CCR3
0
Moreover, while $T1$ inhibited the $T2$ promoter, it acted as a weak transactivator on an artificial promoter consisting of three tandem copies of the consensus myogenic factor DNA binding site.
ITF-2b
creatine kinase
0
Thus, TR6 may play a regulatory role for suppressing in FasL- and $T1$$T2$- and LIGHT-mediated cell death.
LIGHT
FasL
0
Nerve growth factor binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the p140trk ($T1$$T2$, which are both co-expressed in the majority of neuronal cells that respond to NGF.
trkA
p140trk (trkA) tyrosine kinase receptor
0
Nerve growth factor binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to $T1$$T2$) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.
NGF
trkA
0
These data demonstrate that Stat3 but not Stat1 or Stat5 is directly recruited to the ligand-activated $T1$$T2$ by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.
IL-10
IL-10 receptor
0
In the present study, we examined both the binding of $T1$ and $T2$ and the functional consequences of this interaction.
ADA
CD26
1
Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as p16 and p21 and regulators of apoptosis such as p53 and members of the $T1$$T2$ and p21 and regulators of apoptosis such as p53 and members of the bcl-2 family.
bcl-2
p16
0
Because cells lacking the protein tyrosine kinase c-Abl are also defective in radiation-induced G1 arrest, we investigated the possibility that $T1$ might interact with $T2$ in response to radiation damage.
ATM
c-Abl
1
Although the individual amino acids in TrkA involved in binding to nerve growth factor (NGF) and those in TrkC involved in binding to $T1$$T2$) and those in TrkC involved in binding to neurotrophin-3 have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.
neurotrophin-3
NGF
0
In this study, we demonstrate that CD5 is coupled to the protein-tyrosine kinase $T1$ and can act as a substrate for $T2$.
p56lck
p56lck
0
The pattern of CD30L binding inhibition shows only limited correspondence to the functional capacity of some anti-$T1$$T2$ binding inhibition shows only limited correspondence to the functional capacity of some anti-CD30 MAb to trigger CD30 signaling.
CD30
CD30L
0
Previously, we mapped the novel CC chemokine myeloid progenitor inhibitory factor 2 ($T1$)/$T2$ to chromosome 7q11.23 (Nomiyama, H., Osborne, L. R., Imai, T., Kusuda, J., Miura, R., Tsui, L.-C., and Yoshie, O.
MPIF-2
eotaxin-2
0
These data suggest that ADA on the cell surface is involved in an important immunoregulatory mechanism by which released ADA binds to cell surface $T1$$T2$ on the cell surface is involved in an important immunoregulatory mechanism by which released ADA binds to cell surface CD26, and this complex is capable of reducing the local concentration of adenosine.
CD26
ADA
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of $T1$, $T2$/dystrophin related protein, and the Torpedo 87K protein.
dystrophin
utrophin
0
Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the $T1$/CCKB G protein-coupled receptor and the $T2$ receptor.
gastrin
insulin
0
Using a soluble CD30L/CD8alpha chimeric protein, we assessed the ability of anti-$T1$ MAb to inhibit the binding of $T2$ to CD30 expressed by the CD30+ Karpas 299 cell line.
CD30
CD30L
0
CD30 and its counter-receptor CD30 ligand ($T1$$T2$ ligand (CD30L) are members of the TNF-receptor/TNFalpha superfamily and function to regulate lymphocyte survival and differentiation.
CD30L
CD30
0
Finally, we demonstrate that the anti-CD30L MAb M81 also completely inhibits CD30/$T1$$T2$ MAb M81 also completely inhibits CD30/CD30L interaction.
CD30L
CD30L
0
These data suggest that ADA on the cell surface is involved in an important immunoregulatory mechanism by which released $T1$$T2$ on the cell surface is involved in an important immunoregulatory mechanism by which released ADA binds to cell surface CD26, and this complex is capable of reducing the local concentration of adenosine.
ADA
ADA
0
In the present study, we demonstrate that $T1$ stimulates tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the $T2$.
gastrin
insulin receptor
0
The resulting Trk variant recruited binding of NGF equivalent to TrkA, maintained $T1$ binding equivalent to TrkC, and also bound brain-derived neurotrophin, although with lower affinity compared with $T2$.
neurotrophin-3
TrkB
0
The binding of p56lck to CD5 induced a 10- to 15-fold increase in $T1$$T2$ to CD5 induced a 10- to 15-fold increase in p56lck catalytic activity, as measured by in vitro kinase analysis.
p56lck
p56lck
0
TR6 (decoy receptor 3 ($T1$$T2$ (decoy receptor 3 (DcR3)) is a new member of the tumor necrosis factor receptor (TNFR) family.
DcR3
TR6
0
CD5 associates with the T-cell receptor zeta chain ($T1$$T2$ complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/CD3 ligation.
TcR zeta
T-cell receptor zeta chain (TcR zeta)/CD3
0
Interactions between $T1$ and the $T2$.
brain-derived neurotrophic factor
TRKB receptor
1
The conformers that are committed to the native state remained in the supernatant and were assayed after 1 h. At 25 degrees C, the rate profiles indicate the release and commitment to folding of $T1$ to its native state occurs far earlier (t1/2 < 1 min) than for $T2$ (t1/2 = 5 min).
GS
rhodanese
0
In contrast, the renaturation rate for $T1$ with the groE chaperonins mirrored the committed renaturation rates following $T2$ depletion.
rhodanese
groEL
0
The resulting Trk variant recruited binding of NGF equivalent to TrkA, maintained neurotrophin-3 binding equivalent to TrkC, and also bound $T1$, although with lower affinity compared with $T2$.
brain-derived neurotrophin
TrkB
1
We found that ADA was associated with $T1$ on T cell lines lacking either $T2$ or dipeptidyl peptidase IV enzymatic activity, indicating that the association between dipeptidyl peptidase IV and ADA did not require enzymatic activity.
CD26
ADA
0
We have used an interaction cloning strategy to identify an inhibitory isoform of the $T1$ transcription factor, ITF-2b, that interacts with the transcriptional inhibitor $T2$/HLH462.
ITF-2
Id3
0
The interaction can also be observed in vivo, as $T1$ can be co-precipitated with $T2$ from co-transfected Cos1 cells and TBP co-immunoprecipitates with the endogenous Oct1 from HeLa cells.
TBP
Oct2
1
Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, $T1$$T2$ and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.
interleukin (IL) 1
transforming growth factors (TGF) beta1
0
In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of $T1$ (IRS-1), the major cytoplasmic substrate of the $T2$.
insulin receptor substrate 1
insulin receptor
0
The extracellular domain of the human neurotrophin TRKB receptor expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for $T1$ ($T2$).
brain-derived neurotrophic factor
BDNF
0
Interactions between brain-derived neurotrophic factor and the $T1$$T2$ receptor.
TRKB receptor
TRKB
0
Here we have utilized affinity crosslinking agents with 125I-NGF to detect an association of $T1$ and $T2$ receptors in embryonic spinal cord and brain tissues enriched in the two receptors.
trkA
p75
0
The resulting Trk variant recruited binding of NGF equivalent to TrkA, maintained neurotrophin-3 binding equivalent to $T1$, and also bound brain-derived neurotrophin, although with lower affinity compared with $T2$.
TrkC
TrkB
0
$T1$ binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the p140trk ($T2$) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.
Nerve growth factor
trkA
0
$T1$ binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to $T2$.
Nerve growth factor
NGF
0
CD30 and its counter-receptor $T1$ ligand (CD30L) are members of the TNF-receptor/$T2$ superfamily and function to regulate lymphocyte survival and differentiation.
CD30
TNFalpha
0
We show that the POU homeodomain of $T1$ and the evolutionarily conserved C-terminal core domain of $T2$ are both required and sufficient for the interaction.
Oct2
TBP
1
Although the individual amino acids in $T1$ involved in binding to nerve growth factor (NGF) and those in $T2$ involved in binding to neurotrophin-3 have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.
TrkA
TrkC
0
Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine $T1$ were found to be redundantly required for receptor function and for activation of Stat3 but not for $T2$ or Stat5.
IL-10 receptor
Stat1
0
The interaction can also be observed in vivo, as TBP can be co-precipitated with $T1$ from co-transfected Cos1 cells and TBP co-immunoprecipitates with the endogenous $T2$ from HeLa cells.
Oct2
Oct1
0
By using several different experimental systems we show that $T1$ efficiently associates with $T2$ and Oct2.
TBP
Oct1
1
Here, we demonstrate that $T1$ specifically binds two cellular ligands, $T2$ (herpes virus entry mediator (HVEM)-L) and Fas ligand (FasL/CD95L).
TR6
LIGHT
1
The potency of $T1$ as a $T2$ ligand seems, however, to be approximately 10-fold less than that of eotaxin.
eotaxin-3
CCR3
1
Prompted by this hypothesis, we analyzed the genomic region containing the gene for $T1$/$T2$ (SCYA24) and have identified a novel CC chemokine termed eotaxin-3.
MPIF-2
eotaxin-2
0
$T1$ binds independently to two transmembrane receptors, the $T2$ neurotrophin receptor and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.
Nerve growth factor
p75
0
These results, obtained from a variety of experimental techniques, highlight the importance of two distinct regions of the extracellular domain of the $T1$$T2$ in binding BDNF.
TRKB
TRKB receptor
0
In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 ($T1$), the major cytoplasmic substrate of the $T2$ receptor.
IRS-1
insulin
0
Characterization of $T1$ binding to human $T2$ on T cells and its biologic role in immune response.
adenosine deaminase
CD26
1
Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as p16 and p21 and regulators of apoptosis such as $T1$ and members of the $T2$ family.
p53
bcl-2
0
CD5 associates with the T-cell receptor zeta chain (TcR zeta)/$T1$$T2$ complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/CD3 ligation.
CD3
T-cell receptor zeta chain (TcR zeta)/CD3
0
The use of glutathione S-transferase-Lck fusion proteins in precipitation analysis showed that the SH2 domain of $T1$ could recognize $T2$ as expressed in the baculovirus expression system.
p56lck
CD5
1
Using a soluble $T1$/$T2$ chimeric protein, we assessed the ability of anti-CD30 MAb to inhibit the binding of CD30L to CD30 expressed by the CD30+ Karpas 299 cell line.
CD30L
CD8alpha
0
$T1$ also activated Stat5 in Ba/F3 cells that stably expressed the murine $T2$ receptor.
IL-10
IL-10
0
Anti-CD5 also precipitated the kinase from various T cells irrespective of the expression of TcR zeta/CD3 or $T1$$T2$/CD3 or CD4.
CD4
TcR zeta
0
CD26, a T cell activation Ag, also known as $T1$,is directly associated with adenosine deaminase ($T2$) on the surface of T cells and T cell lines.
dipeptidyl peptidase IV
ADA
1
In keeping with this observation, we showed that human CD26-transfected murine pre-B cell lines lacking human ADA acquired $T1$$T2$-transfected murine pre-B cell lines lacking human ADA acquired ADA from an extracellular source.
ADA
CD26
0
The deduced amino acid sequences of human alpha 1- and beta 2-syntrophin are nearly identical to their homologues in mouse, suggesting a strong functional conservation among the individual isoforms, Much like $T1$, human $T2$ has multiple transcript classes and is expressed widely, although in a distinct pattern of relative abundance.
beta 1-syntrophin
beta 2-syntrophin
0
The POU domains of the Oct1 and $T1$ transcription factors mediate specific interaction with $T2$.
Oct2
TBP
1
The crystal structure of the 109-residue amino-terminal domain of $T1$ bound to a 15-residue transactivation domain peptide of $T2$ revealed that MDM2 has a deep hydrophobic cleft on which the p53 peptide binds as an amphipathic alpha helix.
MDM2
p53
1
Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/$T1$ G protein-coupled receptor and the $T2$ receptor.
CCKB
insulin
0
As expected, overexpression of either $T1$/HLH462 or ITF-2b effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor $T2$.
Id3
MyoD
0
The interaction can also be observed in vivo, as TBP can be co-precipitated with Oct2 from co-transfected Cos1 cells and $T1$ co-immunoprecipitates with the endogenous $T2$ from HeLa cells.
TBP
Oct1
1
hPRL does not bind to the hGH receptor, but $T1$ binds to both the hGHR and $T2$, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.
hGH
hPRLR
1
Following gastrin stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of $T1$$T2$ stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase).
phosphatidylinositol 3-kinase
gastrin
0
Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the gastrin/CCKB G protein-coupled receptor and the $T1$$T2$ receptor.
insulin receptor
insulin
0
Using a soluble CD30L/$T1$ chimeric protein, we assessed the ability of anti-$T2$ MAb to inhibit the binding of CD30L to CD30 expressed by the CD30+ Karpas 299 cell line.
CD8alpha
CD30
0
Further, anti-CD5 and anti-$T1$$T2$ and anti-p56lck coprecipitated each other in a variety of detergents, including Nonidet P-40 and Triton X-100.
p56lck
CD5
0
In keeping with this observation, we showed that human CD26-transfected murine pre-B cell lines lacking human ADA acquired $T1$$T2$ acquired ADA from an extracellular source.
ADA
ADA
0
Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine IL-10 receptor were found to be redundantly required for receptor function and for activation of $T1$ but not for $T2$ or Stat5.
Stat3
Stat1
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both $T1$$T2$ receptor (LTbetaR) and HVEM/TR2 receptors.
lymphotoxin beta receptor
lymphotoxin beta
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor (LTbetaR) and $T1$$T2$ triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor (LTbetaR) and HVEM/TR2 receptors.
HVEM
LIGHT
0
hPRL does not bind to the hGH receptor, but $T1$ binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on $T2$ overlap.
hGH
hGH
0
The crystal structure of the 109-residue amino-terminal domain of MDM2 bound to a 15-residue transactivation domain peptide of p53 revealed that $T1$ has a deep hydrophobic cleft on which the $T2$ peptide binds as an amphipathic alpha helix.
MDM2
p53
1
In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of $T1$ receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the $T2$.
insulin
insulin receptor
0
CD5 associates with the T-cell receptor zeta chain ($T1$)/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/$T2$ ligation.
TcR zeta
CD3
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, $T1$/$T2$, and the Torpedo 87K protein.
utrophin
dystrophin related protein
0
As expected, overexpression of either Id3/HLH462 or ITF-2b effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor $T1$$T2$ or ITF-2b effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor MyoD.
MyoD
HLH462
0
CD5 associates with the T-cell receptor zeta chain (TcR zeta)/$T1$ complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/$T2$ ligation.
CD3
CD3
0
Although multimeric complexes of trkA and $T1$ were not detected by affinity crosslinking, immunoprecipitation of cross-linked NGF-receptor complexes with $T2$-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.
p75
trk
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both $T1$$T2$ triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor (LTbetaR) and HVEM/TR2 receptors.
lymphotoxin beta receptor
LIGHT
0
Anti-CD5 also precipitated the kinase from various T cells irrespective of the expression of TcR zeta/CD3 or $T1$$T2$ or CD4.
CD4
CD3
0
The human pituitary hormones, $T1$ ($T2$) and prolactin (hPRL), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.
growth hormone
hGH
0
The binding of p56lck to CD5 induced a 10- to 15-fold increase in $T1$$T2$ induced a 10- to 15-fold increase in p56lck catalytic activity, as measured by in vitro kinase analysis.
p56lck
CD5
0
The interaction can also be observed in vivo, as TBP can be co-precipitated with $T1$ from co-transfected Cos1 cells and $T2$ co-immunoprecipitates with the endogenous Oct1 from HeLa cells.
Oct2
TBP
0
Anti-CD5 also precipitated the kinase from various T cells irrespective of the expression of TcR zeta/$T1$$T2$ also precipitated the kinase from various T cells irrespective of the expression of TcR zeta/CD3 or CD4.
CD3
CD5
0
Following gastrin stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of phosphatidylinositol 3-kinase ($T1$$T2$ stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase).
PI 3-kinase
gastrin
0
These data demonstrate that Stat3 but not Stat1 or Stat5 is directly recruited to the ligand-activated $T1$$T2$ but not Stat1 or Stat5 is directly recruited to the ligand-activated IL-10 receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.
IL-10
Stat3
0
Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine $T1$$T2$ were found to be redundantly required for receptor function and for activation of Stat3 but not for Stat1 or Stat5.
IL-10
IL-10 receptor
0
Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated Stat3 but not Stat1 and blocked $T1$$T2$ and blocked IL-10-induced Stat3 phosphorylation in a cell-free system.
IL-10
Stat1
0
The extracellular domain of the human $T1$$T2$ receptor expressed in Chinese hamster ovary cells is a highly glycosylated protein, possessing binding ability for brain-derived neurotrophic factor (BDNF).
neurotrophin TRKB receptor
TRKB
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/$T1$$T2$, and the Torpedo 87K protein.
dystrophin
dystrophin related protein
0
We have previously reported that tyrosine phosphorylation of Shc and its association with the Grb2-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by $T1$$T2$ pathway by gastrin.
gastrin
mitogen-activated protein kinase
0
Nerve growth factor binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the $T1$$T2$ neurotrophin receptor and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.
p140trk
p75
0
CD26, a T cell activation Ag, also known as $T1$$T2$, a T cell activation Ag, also known as dipeptidyl peptidase IV,is directly associated with adenosine deaminase (ADA) on the surface of T cells and T cell lines.
dipeptidyl peptidase IV
CD26
0
Using immunoprecipitation techniques, we have determined the rates at which $T1$ and $T2$ (GS) are released from groEL in a form committed to refold to active enzyme.
rhodanese
glutamine synthetase
0
Characterization of the $T1$ binding domain on the human CD30 molecule using anti-$T2$ antibodies.
CD30L
CD30
0
The human pituitary hormones, growth hormone (hGH) and prolactin ($T1$$T2$) and prolactin (hPRL), regulate a large variety of physiological processes, among which are growth and differentiation of muscle, bone and cartilage cells, and lactation.
hPRL
hGH
0
Following gastrin stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of phosphatidylinositol 3-kinase ($T1$$T2$ (PI 3-kinase).
PI 3-kinase
phosphatidylinositol 3-kinase
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and $T1$ interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the $T2$.
alpha 1-syntrophin
Torpedo 87K protein
1
Although the individual amino acids in TrkA involved in binding to nerve growth factor (NGF) and those in $T1$ involved in binding to $T2$ have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.
TrkC
neurotrophin-3
1
Here, we demonstrate that TR6 specifically binds two cellular ligands, $T1$ (herpes virus entry mediator ($T2$)-L) and Fas ligand (FasL/CD95L).
LIGHT
HVEM
0
hPRL does not bind to the hGH receptor, but hGH binds to both the $T1$ and $T2$, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.
hGHR
hPRLR
0
Here, we demonstrate that TR6 specifically binds two cellular ligands, LIGHT (herpes virus entry mediator ($T1$)-L) and Fas ligand ($T2$/CD95L).
HVEM
FasL
0
In this study, a minimum set of residues in the human TrkC second immunoglobulin-like domain, which does not bind nerve growth factor (NGF), were substituted with those from human $T1$$T2$ (NGF), were substituted with those from human TrkA.
TrkA
nerve growth factor
0
We found that $T1$ was associated with CD26 on T cell lines lacking either $T2$ or dipeptidyl peptidase IV enzymatic activity, indicating that the association between dipeptidyl peptidase IV and ADA did not require enzymatic activity.
ADA
ADA
0
CD30 and its counter-receptor $T1$ ($T2$) are members of the TNF-receptor/TNFalpha superfamily and function to regulate lymphocyte survival and differentiation.
CD30 ligand
CD30L
0
Mechanism of CDK activation revealed by the structure of a $T1$-$T2$ complex.
cyclinA
CDK2
1
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and $T1$ interact with peptides encoding the syntrophin-binding region of $T2$, utrophin/dystrophin related protein, and the Torpedo 87K protein.
alpha 1-syntrophin
dystrophin
1
In the present study, we demonstrate that $T1$ stimulates tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the $T2$ receptor.
gastrin
insulin
0
Nerve growth factor binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to $T1$$T2$, which are both co-expressed in the majority of neuronal cells that respond to NGF.
NGF
p140trk (trkA) tyrosine kinase receptor
0
CD30 and its counter-receptor $T1$$T2$ ligand (CD30L) are members of the TNF-receptor/TNFalpha superfamily and function to regulate lymphocyte survival and differentiation.
CD30 ligand
CD30
0
We have previously reported that tyrosine phosphorylation of Shc and its association with the Grb2-Sos complex may contribute to the activation of the $T1$$T2$ and its association with the Grb2-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by gastrin.
mitogen-activated protein kinase
Shc
0
$T1$ stimulates tyrosine phosphorylation of $T2$ receptor substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.
Gastrin
insulin
0
Moreover, using immunoelectron microscopy, we demonstrated that $T1$ and ADA co-localized on the cell surface, but not inside cells, suggesting that CD26 did not transport $T2$ to the surface.
CD26
ADA
0
Although multimeric complexes of $T1$ and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked NGF-receptor complexes with $T2$-specific antibodies resulted in selective immunoprecipitation of crosslinked p75.
trkA
trk
0
$T1$ and its counter-receptor $T2$ (CD30L) are members of the TNF-receptor/TNFalpha superfamily and function to regulate lymphocyte survival and differentiation.
CD30
CD30 ligand
1
CD5 associates with the T-cell receptor zeta chain (TcR zeta)/$T1$ complex and is rapidly phosphosphorylated on tyrosine residues as a result of $T2$/CD3 ligation.
CD3
TcR zeta
0
The interface relies on the steric complementarity between the MDM2 cleft and the hydrophobic face of the $T1$ alpha helix and, in particular, on a triad of p53 amino acids-Phe19, Trp23, and Leu26-which insert deep into the $T2$ cleft.
p53
MDM2
0
The $T1$ POU domain, which is highly homologous to the $T2$ POU domain, likewise mediates interaction with TBP.
Oct1
Oct2
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and $T1$ interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/$T2$, and the Torpedo 87K protein.
alpha 1-syntrophin
dystrophin related protein
1
We have previously reported that tyrosine phosphorylation of Shc and its association with the Grb2-$T1$ complex may contribute to the activation of the mitogen-activated protein kinase pathway by $T2$.
Sos
gastrin
0
These data demonstrate that Stat3 but not $T1$ or Stat5 is directly recruited to the ligand-activated $T2$ by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine.
Stat1
IL-10 receptor
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor (LTbetaR) and $T1$$T2$) and HVEM/TR2 receptors.
HVEM
LTbetaR
0
Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine $T1$ were found to be redundantly required for receptor function and for activation of $T2$ but not for Stat1 or Stat5.
IL-10 receptor
Stat3
1
The novel fold of the TNF receptor structure is likely to be representative of the nerve growth factor ($T1$$T2$ (NGF)/TNF receptor family as a whole.
NGF
nerve growth factor
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of $T1$, utrophin/$T2$, and the Torpedo 87K protein.
dystrophin
dystrophin related protein
0
$T1$ competed the binding of (125)I-eotaxin to $T2$-expressing L1.2 cells with an IC(50) of 13 nM.
Eotaxin-3
CCR3
1
$T1$ associates with the T-cell receptor zeta chain (TcR zeta)/$T2$ complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/CD3 ligation.
CD5
CD3
0
Prompted by this hypothesis, we analyzed the genomic region containing the gene for MPIF-2/eotaxin-2 ($T1$) and have identified a novel CC chemokine termed $T2$.
SCYA24
eotaxin-3
0
This information is useful for applying these MAbs in functional studies to further investigate the CD30/CD30L system and for designing assays for soluble $T1$$T2$ system and for designing assays for soluble CD30L.
CD30L
CD30L
0
Nerve growth factor binds independently to two transmembrane receptors, the $T1$ and the $T2$, which are both co-expressed in the majority of neuronal cells that respond to NGF.
p75 neurotrophin receptor
p140trk (trkA) tyrosine kinase receptor
0
$T1$ does not bind to the hGH receptor, but hGH binds to both the hGHR and $T2$, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.
hPRL
hPRLR
0
We have previously reported that tyrosine phosphorylation of Shc and its association with the Grb2-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by $T1$$T2$ and its association with the Grb2-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by gastrin.
gastrin
Shc
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor (LTbetaR) and HVEM/$T1$$T2$ triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor (LTbetaR) and HVEM/TR2 receptors.
TR2
LIGHT
0
The self-association site appears to be formed by interactions between helices 1 and 2 of $T1$ repeat 17 of one dimer with helix 3 of $T2$ repeat 1 of the other dimer to form two combined alpha-beta triple-helical segments.
beta spectrin
alpha spectrin
1
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like $T1$, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/$T2$, and the Torpedo 87K protein.
beta 1-syntrophin
dystrophin related protein
1
Taken together, our results suggest that IRS-1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families, such as the $T1$/CCKB G protein-coupled receptor and the $T2$.
gastrin
insulin receptor
0
The interface relies on the steric complementarity between the MDM2 cleft and the hydrophobic face of the $T1$ alpha helix and, in particular, on a triad of $T2$ amino acids-Phe19, Trp23, and Leu26-which insert deep into the MDM2 cleft.
p53
p53
0
Our data suggest that TR6 inhibits the interactions of $T1$ with HVEM/TR2 and $T2$, thereby suppressing LIGHT- mediated HT29 cell death.
LIGHT
LTbetaR
1
Further investigation indicated that the ITF-2b/$T1$ heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by $T2$/HLH462.
MyoD
Id3
0
It has been shown that LIGHT triggers apoptosis of various tumor cells including HT29 cells that express both $T1$$T2$ triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor (LTbetaR) and HVEM/TR2 receptors.
lymphotoxin beta
LIGHT
0
CD5 associates with the $T1$ ($T2$)/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/CD3 ligation.
T-cell receptor zeta chain
TcR zeta
0
In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of $T1$ receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the $T2$ receptor.
insulin
insulin
0
Prompted by this hypothesis, we analyzed the genomic region containing the gene for MPIF-2/$T1$ ($T2$) and have identified a novel CC chemokine termed eotaxin-3.
eotaxin-2
SCYA24
0
Gastrin stimulates tyrosine phosphorylation of $T1$$T2$ receptor substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.
insulin receptor
insulin
0
In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of $T1$ (IRS-1), the major cytoplasmic substrate of the $T2$ receptor.
insulin receptor substrate 1
insulin
0
We present here the crystal structure of the 1:1 complex of $T1$ bound to the extracellular domain of the $T2$.
hGH
hPRLR
1
Using a soluble CD30L/CD8alpha chimeric protein, we assessed the ability of anti-CD30 MAb to inhibit the binding of $T1$ to $T2$ expressed by the CD30+ Karpas 299 cell line.
CD30L
CD30
1
Although multimeric complexes of trkA and p75 were not detected by affinity crosslinking, immunoprecipitation of cross-linked NGF-receptor complexes with $T1$-specific antibodies resulted in selective immunoprecipitation of crosslinked $T2$.
trk
p75
0
CD5 associates with the T-cell receptor zeta chain (TcR zeta)/CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of $T1$/$T2$ ligation.
TcR zeta
CD3
0
Here, we demonstrate that TR6 specifically binds two cellular ligands, $T1$ (herpes virus entry mediator (HVEM)-L) and Fas ligand (FasL/$T2$).
LIGHT
CD95L
0
Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine $T1$ receptor were found to be redundantly required for receptor function and for activation of Stat3 but not for $T2$ or Stat5.
IL-10
Stat1
0
In this study, a minimum set of residues in the human $T1$ second immunoglobulin-like domain, which does not bind $T2$ (NGF), were substituted with those from human TrkA.
TrkC
nerve growth factor
0
Although the individual amino acids in TrkA involved in binding to $T1$ ($T2$) and those in TrkC involved in binding to neurotrophin-3 have been mapped in this domain, the Trk amino acids that provide specificity remained unclear.
nerve growth factor
NGF
0
Cluster Group B antibodies, including M67 and Ki-1, do not affect $T1$ binding to $T2$.
CD30L
CD30
1
$T1$ interaction w$T2$ p56lck represents a novel variant of a receptor-kinase complex in which receptor can also serve as substrate.
CD5
ith
0
hPRL does not bind to the $T1$ receptor, but hGH binds to both the hGHR and $T2$, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.
hGH
hPRLR
0
Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated Stat3 but not Stat1 and blocked IL-10-induced $T1$$T2$ and blocked IL-10-induced Stat3 phosphorylation in a cell-free system.
Stat3
Stat1
0
Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/$T1$, and the $T2$.
dystrophin related protein
Torpedo 87K protein
0
Using a structure-function mutagenesis approach, two tyrosine residues (Tyr427 and Tyr477) in the intracellular domain of the murine $T1$ receptor were found to be redundantly required for receptor function and for activation of $T2$ but not for Stat1 or Stat5.
IL-10
Stat3
0
Comparisons with the $T1$-$T2$ complex reveal how hGH can bind to the two distinctly different receptor binding surfaces.
hGH
hGHR
1
The X-ray structure of a $T1$-$T2$ receptor complex.
growth hormone
prolactin
0
In a previous work, we predicted and demonstrated that the 29-42-residue fragment of $T1$ ($T2$) has in vitro capacities close to those of the tilted fragment of viral fusion proteins.
beta-amyloid peptide
Abeta peptide
0
The crystal structure of the 109-residue amino-terminal domain of MDM2 bound to a 15-residue transactivation domain peptide of p53 revealed that MDM2 has a deep hydrophobic cleft on which the $T1$$T2$ bound to a 15-residue transactivation domain peptide of p53 revealed that MDM2 has a deep hydrophobic cleft on which the p53 peptide binds as an amphipathic alpha helix.
p53
MDM2
0
$T1$ inhibited $T2$-induced cytotoxicity in HT29 cells.
TR6
LIGHT
0
This information is useful for applying these MAbs in functional studies to further investigate the CD30/CD30L system and for designing assays for soluble $T1$$T2$/CD30L system and for designing assays for soluble CD30L.
CD30L
CD30
0
To define the mechanism underlying signal transducer and activator of transcription (STAT) protein recruitment to the interleukin 10 ($T1$$T2$ (IL-10) receptor, the STAT proteins activated by IL-10 in different cell populations were first defined using electrophoretic mobility shift assays.
IL-10
interleukin 10
0
Our data suggest that TR6 inhibits the interactions of $T1$ with $T2$/TR2 and LTbetaR, thereby suppressing LIGHT- mediated HT29 cell death.
LIGHT
HVEM
1
The POU domains of the $T1$ and Oct2 transcription factors mediate specific interaction with $T2$.
Oct1
TBP
1
Here, we demonstrate that TR6 specifically binds two cellular ligands, LIGHT ($T1$) and $T2$ (FasL/CD95L).
herpes virus entry mediator (HVEM)-L
Fas ligand
0
These same $T1$ residues are also involved in transactivation, supporting the hypothesis that $T2$ inactivates p53 by concealing its transactivation domain.
p53
MDM2
0
Our data suggest that TR6 inhibits the interactions of LIGHT with $T1$/TR2 and LTbetaR, thereby suppressing $T2$- mediated HT29 cell death.
HVEM
LIGHT
0
Eotaxin-3 competed the binding of (125)$T1$ to $T2$-expressing L1.2 cells with an IC(50) of 13 nM.
I-eotaxin
CCR3
1
CD5 associates with the $T1$ complex and is rapidly phosphosphorylated on tyrosine residues as a result of $T2$/CD3 ligation.
T-cell receptor zeta chain (TcR zeta)/CD3
TcR zeta
0
CD26, a T cell activation Ag, also known as dipeptidyl peptidase IV,is directly associated with adenosine deaminase ($T1$$T2$ (ADA) on the surface of T cells and T cell lines.
ADA
adenosine deaminase
0
These results, obtained from a variety of experimental techniques, highlight the importance of two distinct regions of the extracellular domain of the $T1$ receptor in binding $T2$.
TRKB
BDNF
0
The crystal structure of the human $T1$-$T2$ (CDK2)-ATP complex has been determined at 2.3 A resolution.
cyclinA
cyclin-dependent kinase2
1
The resulting Trk variant recruited binding of NGF equivalent to $T1$, maintained neurotrophin-3 binding equivalent to TrkC, and also bound $T2$, although with lower affinity compared with TrkB.
TrkA
brain-derived neurotrophin
0
We have used an interaction cloning strategy to identify an inhibitory isoform of the $T1$ transcription factor, $T2$, that interacts with the transcriptional inhibitor Id3/HLH462.
ITF-2
ITF-2b
0
